Delivery Order SPE2DB24D1201-SPE2DB25FJAJD

Award Date 11/4/24
Potential Completion Date 11/5/24
Potential Value $3.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $5,016.65 firm fixed-price delivery order is for the pharmaceutical product EMVERM 100 MG TABLET CHEW UDS. The contract has an ultimate completion date of October 16, 2023. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,624.71 firm fixed-price delivery order is for the supply of EMVERM 100 MG TABLET CHEW UDS, a pharmaceutical product. The contract has an ultimate completion date of July 2, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,652.39, is for the delivery of EMVERM 100 MG TABLET CHEW UDS medical supplies. The award is a Firm Fixed Price Delivery Order with an ultimate completion date of April 3, 2025. This contract is not designated as a set-aside and was likely competed openly....
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $36,051.18 firm fixed-price contract is for the supply of EMVERM 100 MG TABLET CHEW UDS, a medical product, with an ultimate completion date of February 27, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $59,278.76 Firm Fixed Price Delivery Order contract is for the supply of the medication EMVERM 100 MG TABLET CHEW UDS. The award has an ultimate completion date of December 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which...
This is a $3,129.73 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of EMVERM 100 MG TABLET CHEW UDS and has an ultimate completion date of April 10, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award, with ID SPE2DB20D1109|SPE2DB24FN43H, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,693.48 Firm Fixed Price Delivery Order covers the procurement of EMVERM 100 MG TABLET CHEW UDS medical supplies, with a period of performance ending on January 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,613.24, is for the delivery of EMVERM 100 MG TABLET CHEW UDS, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of December 27, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery...
This contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, covers the delivery of 4557841419 EMVERM 100 MG TABLET CHEW UDS. The $3,546.70 firm fixed price Delivery Order has a completion date of July 20, 2022 and was awarded on July 19, 2022. This contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
This federal contract award, valued at $1,872.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of EMVERM 100 MG TABLET CHEW UDS. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of October 11, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract to supply the specified pharmaceutical product to support military treatment facilities and federal...
  • SPE2DB24D1201
    Indefinite Delivery Contract
  • SPE2DB24D1201-SPE2DB25FJAJD
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,275.38 firm fixed-price delivery order is for the supply of EMVERM 100 MG TABLET CHEW UDS, a medical product. The contract has an ultimate completion date of November 5, 2024.

Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

This contract award was not designated with any set-aside requirements, indicating open competition.

Generated 5/20/25, 2:00 PM